Required fields are marked with *

Verification code

FSL-1-TFA

{PARAM:[Name]}()
Category Herpes simplex Virus (HSV)
Description FSL-1 TFA, a bacterial-derived toll-like receptor 2/6 (TLR2/6) agonist, enhances resistance to experimental HSV-2 infection.
Quotation Now

Product Information

Synonyms FSL-1 (TFA)|CS-0130017
Molecular Weight 1780.18
Molecular Formula C82H141F3N14O20S
Boiling Point 1659.8±65.0 °C at 760 mmHg
Flash Point 957.6±34.3 °C
Purity 99.58%
Density 1.2±0.1 g/cm3
Solubility In Vitro:
H2O
Appearance White to off-white (Solid)
Storage Sealed storage, away from moisture and light
Powder
-80°C 2 years
-20°C 1 years
* In solvent
-80°C 6 months
-20°C 1 month (sealed storage, away from moisture and light)
Index Of Refraction 1.553
In Vitro FSL-1 significantly reduces HSV-2 replication in human vaginal epithelial cells (EC).
FSL-1 induces significant resistance to experimental genital HSV-2 infection through elaboration of a specific cytokine response profile.
FSL-1 (50 ng/mL, 24 hours) induces MMP-9 expression at both mRNA and protein levels in human monocytic THP-1 cells.
FSL-1 activates the MAP kinase/NF-κB signaling pathway.
In Vivo FSL-1 application significantly protectes against genital HSV-2 challenge in mice.
Target Toll-like Receptor (TLR); MMP; HSV; Antibiotic
Vapor Pressure 0.0±0.3 mmHg at 25°C

TAKE YOUR NEXT STEPS

Get Started With Our Industry Experience And Client-Centric Focus!

Talk to Us

Copyright © 2024 BOC Sciences. All rights reserved.